Sinovac Biotech (SVA) is scheduled to report FY earnings on August 29, 2026.
Analyze the earnings history of Sinovac Biotech using advanced sorting and filters.
The chart below shows Sinovac Biotech's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Sinovac Biotech's reported revenue compared to analyst estimates over recent quarters.
Sinovac Biotech (SVA) is scheduled to report earnings on August 29, 2026. The last reported earnings were for reported on May 8, 2026 for H1.
The Actual EPS was $0.06, which beat the estimate of $0.00.
The Actual Revenue was $130.27M, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | 2024-04-29 | $-1.32 | $-0.13 | -915.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| FY | 2024-04-29 | $448.27M | $0 | 100.0 % |